longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Sinobioway Medicine

002581

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -23.29, within the reasonable range, cheaper than 45.78% of the time in the past 3 years, and the industry ranks 191/222, the industry Median 23.71.

-23.29xP/E
¥5.10Stock price
¥-0.22Earnings per share
-23.29xP/E
Stock price¥5.10Earnings per share¥-0.22

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-23.84x
Typical range
-44.46x–-19.21x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.71x
019385776

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.71x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688506SHBIOKIN PHARMACEUTICAL
-63.52x15.13%¥99.92B
000661SZCCHT
-83.11x588.46%¥29.30B
300255SZCSBIO
-61.01x--¥21.08B
300436SZCosunter
-64.12x--¥14.06B
300363SZPorton
-86.15x105.56%¥13.35B
000908SZCSPC Jingfeng
-248.26x--¥10.54B
301263SZT&K
-2,059.99x--¥9.75B
002099SZHISOAR
-58.83x--¥9.96B
688505SHFudan-Zhangjiang
-70.19x--¥8.86B
688176SHAsieris
-16.95x8.11%¥8.35B
002082SZWBDE
-67.56x--¥7.93B
600252SHZhongheng Group
-16.22x--¥7.01B
000813SZDEZHAN HEALTHCARE
-18.78x--¥6.77B
300267SZER-KANG
-18.03x--¥6.72B
002737SZSFPM
-25.64x--¥6.66B
002424SZGZBL
-51.50x--¥6.50B
600422SHKPC
-28.91x53.62%¥6.14B
000566SZHAINAN HAIYAO
-12.39x--¥5.99B
688658SHYKYY
-23.53x--¥6.32B
688197SHShouyao Holdings
-65.56x--¥5.61B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.